JPS6330286B2 - - Google Patents
Info
- Publication number
- JPS6330286B2 JPS6330286B2 JP57011116A JP1111682A JPS6330286B2 JP S6330286 B2 JPS6330286 B2 JP S6330286B2 JP 57011116 A JP57011116 A JP 57011116A JP 1111682 A JP1111682 A JP 1111682A JP S6330286 B2 JPS6330286 B2 JP S6330286B2
- Authority
- JP
- Japan
- Prior art keywords
- substance
- mice
- chlorella
- administered
- glycoprotein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 241000195649 Chlorella <Chlorellales> Species 0.000 claims description 12
- 102000003886 Glycoproteins Human genes 0.000 claims description 7
- 108090000288 Glycoproteins Proteins 0.000 claims description 7
- 239000002246 antineoplastic agent Substances 0.000 claims description 6
- 102000004169 proteins and genes Human genes 0.000 claims description 4
- 108090000623 proteins and genes Proteins 0.000 claims description 4
- 235000016425 Arthrospira platensis Nutrition 0.000 claims description 3
- 240000002900 Arthrospira platensis Species 0.000 claims description 3
- 229940082787 spirulina Drugs 0.000 claims description 3
- 241000195663 Scenedesmus Species 0.000 claims description 2
- 229940041181 antineoplastic drug Drugs 0.000 claims description 2
- 239000000126 substance Substances 0.000 description 18
- 241000699670 Mus sp. Species 0.000 description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 239000000843 powder Substances 0.000 description 7
- 150000001408 amides Chemical class 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 241000195493 Cryptophyta Species 0.000 description 5
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 4
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 4
- XLYOFNOQVPJJNP-ZSJDYOACSA-N Heavy water Chemical compound [2H]O[2H] XLYOFNOQVPJJNP-ZSJDYOACSA-N 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 230000009102 absorption Effects 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 125000000539 amino acid group Chemical group 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 4
- 239000012528 membrane Substances 0.000 description 4
- 241000894007 species Species 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 208000028018 Lymphocytic leukaemia Diseases 0.000 description 3
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- 241000283973 Oryctolagus cuniculus Species 0.000 description 3
- 230000001093 anti-cancer Effects 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 239000000470 constituent Substances 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 230000002209 hydrophobic effect Effects 0.000 description 3
- 208000003747 lymphoid leukemia Diseases 0.000 description 3
- 230000004083 survival effect Effects 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- YZCKVEUIGOORGS-OUBTZVSYSA-N Deuterium Chemical compound [2H] YZCKVEUIGOORGS-OUBTZVSYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 238000001069 Raman spectroscopy Methods 0.000 description 2
- 208000006268 Sarcoma 180 Diseases 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 229910052786 argon Inorganic materials 0.000 description 2
- 238000005452 bending Methods 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 230000002354 daily effect Effects 0.000 description 2
- 229910052805 deuterium Inorganic materials 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- OIPPWFOQEKKFEE-UHFFFAOYSA-N orcinol Chemical compound CC1=CC(O)=CC(O)=C1 OIPPWFOQEKKFEE-UHFFFAOYSA-N 0.000 description 2
- 150000003214 pyranose derivatives Chemical group 0.000 description 2
- 230000000241 respiratory effect Effects 0.000 description 2
- 238000004062 sedimentation Methods 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 238000004114 suspension culture Methods 0.000 description 2
- 238000002054 transplantation Methods 0.000 description 2
- 210000004881 tumor cell Anatomy 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical group O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 description 1
- 229920000310 Alpha glucan Polymers 0.000 description 1
- 229920002498 Beta-glucan Polymers 0.000 description 1
- GUBGYTABKSRVRQ-WFVLMXAXSA-N DEAE-cellulose Chemical compound OC1C(O)C(O)C(CO)O[C@H]1O[C@@H]1C(CO)OC(O)C(O)C1O GUBGYTABKSRVRQ-WFVLMXAXSA-N 0.000 description 1
- 229920001503 Glucan Polymers 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 238000004566 IR spectroscopy Methods 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 239000012980 RPMI-1640 medium Substances 0.000 description 1
- 229920005654 Sephadex Polymers 0.000 description 1
- 239000012507 Sephadex™ Substances 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 230000022534 cell killing Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 229940044683 chemotherapy drug Drugs 0.000 description 1
- 238000001142 circular dichroism spectrum Methods 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 238000012136 culture method Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000009036 growth inhibition Effects 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 238000000760 immunoelectrophoresis Methods 0.000 description 1
- 230000003308 immunostimulating effect Effects 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 238000004816 paper chromatography Methods 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP57011116A JPS58128322A (ja) | 1982-01-27 | 1982-01-27 | 制癌剤 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP57011116A JPS58128322A (ja) | 1982-01-27 | 1982-01-27 | 制癌剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS58128322A JPS58128322A (ja) | 1983-07-30 |
| JPS6330286B2 true JPS6330286B2 (enrdf_load_html_response) | 1988-06-17 |
Family
ID=11769033
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP57011116A Granted JPS58128322A (ja) | 1982-01-27 | 1982-01-27 | 制癌剤 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS58128322A (enrdf_load_html_response) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6219528A (ja) * | 1985-07-16 | 1987-01-28 | Kurorera Kogyo Kk | 制癌剤 |
| JPS63239231A (ja) * | 1987-03-27 | 1988-10-05 | Kurorera Kogyo Kk | 分化誘導剤 |
| CN1098707C (zh) * | 1999-07-19 | 2003-01-15 | 齐清 | 含藻蛋白多糖提取物的药物组合物以及藻蛋白多糖的提取 |
| JP5081485B2 (ja) * | 2007-04-05 | 2012-11-28 | 野田食菌工業株式会社 | 抗癌剤及び抗癌剤の製造方法 |
| CA2723484A1 (en) * | 2008-05-06 | 2009-11-12 | Ocean Nutrition Canada Limited | Compositions obtained from chlorella extract having immunomodulating properties |
-
1982
- 1982-01-27 JP JP57011116A patent/JPS58128322A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS58128322A (ja) | 1983-07-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US2563794A (en) | Vitamin b12 | |
| CA1262016A (en) | Anticancer agent | |
| WO2001002597A1 (en) | Process for the preparation of the polysaccharides k4 and k5 from escherichia coli | |
| HU188599B (en) | Process for preparing physiologically active substance designated as ch-1 | |
| JPS6330286B2 (enrdf_load_html_response) | ||
| JPH06507077A (ja) | 細菌高分子の抽出物、その調製のための方法及び前記抽出物を含む製薬組成物 | |
| US4614733A (en) | Polysaccharides pharmaceutical compositions and the use thereof | |
| US4687764A (en) | Hypotriglyceridemically active polysaccharides | |
| Manzoni et al. | Production and purification of an extracellularly produced K4 polysaccharide from Escherichia coli | |
| US10702564B2 (en) | Blood pressure lowering composition containing as active ingredient exopolysaccharide produced by means of ceriporia lacerata | |
| CN107778357B (zh) | 一种纽莫康定b0的提取、纯化方法 | |
| JPS60246396A (ja) | 酵素阻害物質ジヒドロデスオキシグリゼオ−ル酸及びその塩類 | |
| JPH0347200A (ja) | マカラスムギ由来の糖タンパク質、その製造法及びそれを含有する免疫調節剤 | |
| JPH0721003B2 (ja) | 多糖体およびその製造方法 | |
| CN113717293A (zh) | 一种软珊瑚多糖及其制备方法与应用 | |
| EP0468504A1 (en) | A novel antibiotic, balhimycin, a process for its production and its use as pharmaceutical | |
| CN116421708B (zh) | 鸽蛋清中卵白蛋白的提取及其在伤口修复方面的应用 | |
| JPS6212227B2 (enrdf_load_html_response) | ||
| JPH0156074B2 (enrdf_load_html_response) | ||
| JPS6169728A (ja) | 制癌剤 | |
| GB2625978A (en) | Compositions and uses of oligo-chromopeptides and methods of making | |
| KR20020071390A (ko) | 미생물을 이용한 히알루론산의 제조방법 | |
| CN117903280A (zh) | 一种羊胎盘抗肿瘤蛋白的制备方法及其应用 | |
| KR100566938B1 (ko) | 자라 조펩티드의 제조방법 | |
| NO155697B (no) | Fremgangsmaate for fremstilling av fysiologisk aktive forbindelser ved fermentering. |